Family Medicine Initiative

APRIL 9, 2024

In March 2024, FDA therefore approved semaglutide for secondary CVD prevention in overweight or obese adults. 4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. over 40 months (ARR). semaglutide 2.4 mg or placebo for 52 weeks.

Diabetes 130

Diabetes Patients Medical DO 130

GeriPal

JANUARY 18, 2024

ABIM MOC credit will be offered to subscribers in November, 2024. Why would CBT work for neuropathic pain and diabetes differently than it would work for neuropathic pain and cancer? Have you had a family history of substance use disorder? For any MOC questions, please email moc@ucsf.edu. Why would that be?

Illness 136

Illness Patient-Centered Screening Clinic 136

Maine Academy of Family Physicians

JUNE 21, 2024

Pat Connolly reported on the 2024 Maine Legislative Session: It was a short but busy session in Augusta this year. Pat Connolly & Cortney Linville who attended the AAFP Family Medicine Advocacy Summit in Washington May 19-21. Here in Maine the "shorter" Legislative Session was quite full!

Family Physician 40

Family Physician Family Medicine DO Primary Care 40